Correlation Between Vinhomes JSC and Daklak Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vinhomes JSC and Daklak Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vinhomes JSC and Daklak Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vinhomes JSC and Daklak Pharmaceutical Medical, you can compare the effects of market volatilities on Vinhomes JSC and Daklak Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vinhomes JSC with a short position of Daklak Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vinhomes JSC and Daklak Pharmaceutical.

Diversification Opportunities for Vinhomes JSC and Daklak Pharmaceutical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vinhomes and Daklak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vinhomes JSC and Daklak Pharmaceutical Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daklak Pharmaceutical and Vinhomes JSC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vinhomes JSC are associated (or correlated) with Daklak Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daklak Pharmaceutical has no effect on the direction of Vinhomes JSC i.e., Vinhomes JSC and Daklak Pharmaceutical go up and down completely randomly.

Pair Corralation between Vinhomes JSC and Daklak Pharmaceutical

If you would invest (100.00) in Daklak Pharmaceutical Medical on September 20, 2024 and sell it today you would earn a total of  100.00  from holding Daklak Pharmaceutical Medical or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Vinhomes JSC  vs.  Daklak Pharmaceutical Medical

 Performance 
       Timeline  
Vinhomes JSC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vinhomes JSC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, Vinhomes JSC is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Daklak Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Daklak Pharmaceutical Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Daklak Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Vinhomes JSC and Daklak Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vinhomes JSC and Daklak Pharmaceutical

The main advantage of trading using opposite Vinhomes JSC and Daklak Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vinhomes JSC position performs unexpectedly, Daklak Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daklak Pharmaceutical will offset losses from the drop in Daklak Pharmaceutical's long position.
The idea behind Vinhomes JSC and Daklak Pharmaceutical Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments